in

Ironwood Pharmaceuticals CEO Peter Hecht Resigned

Ironwood CEO stepping down to run spinoff biotech – The Boston Globe

Ironwood has developed medicines for gastrointestinal diseases, including Linzess, and is among a relatively small group of Cambridge biotechs with approved drugs on the market. But the 21-year-old company, under pressure from an activist investor to increase the value of its stock, announced in May that it planned to split into two independent publicly traded firms. Terrance G.


Name: Peter Hecht

Continent: North America

Country: USA

Company: Ironwood Pharmaceuticals

Branch: Pharma

Position: CEO

Reason: Resigned

New Company: Cyclerion Therapeutics

New Position: CEO

Announcement Date: January 03, 2019, 11:00pm

Resignation Date: January 03, 2019, 11:00pm

Source 1: https://www.bostonglobe.com/business/2019/01/04/ironwood-ceo-stepping-down-run-spinoff-biotech/cabczecyaOh7YPtapHhjEP/story.html


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply